The role of nuclear medicine in breast cancer detection: Functional breast imaging

Radiologic Clinics of North America

Volumn 39, Issue 5, 2001, Pages 1053-1068

  Khalkhali, Iraj ^a,b,c   Vargas, Hernan I ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Breast Diagnostic Center   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

BREAST CANCER; CANCER DIAGNOSIS; CANCER LOCALIZATION; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MAMMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCINTIMAMMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0034808611     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-8389(05)70328-6     Document Type: Article

References (68)

1. Uptake of Tc99m Tetrofosmin, Tc99m MIBI and TI-201 in tumor cell lines
2. Staging of cancer
3. Positron emission tomography for in vivo measurement of regional blood flow, oxygen utilization and blood volume in patients with breast carcinoma
4. Detection of multidrug resistance with technetium 99m sestamibi
5. Tc99m diphosphonate concentration in primary breast cancer
6. Uptake of Tc99m MIBI related to tumor size and type. Anticancer Res 17:
7. The efficacy of the classification "Probably benign: Short term follow up suggested."
8. Cellular distribution and analysis of Tc99m MIBI in isolated perfused rat hearts
9. Extraosseous noncalcified soft tissue uptake of 99m Tc-polyphosphate
10. Technetium 99m sestamibi efflux P-glycoprotein expression in human breast carcinoma
11. Tumor clearance of technetium 99m sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer
12. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: Correlation with MDR gene expression
13. Thallium 201 chloride uptake in tumors: A possible complication in heart scintigraphy
14. Tc99m sestamibi scintimammography for the evaluation of breast masses in patients with radiographically dense breasts
15. Immunohistologic assessment of technetium 99m-MIBI uptake in benign and malignant breast lesions
16. The effect of chemotherapy on the uptake of technetium-99m sestamibi in breast cancer
17. Correlation between uptake of Tc99m sestamibi and prognostic factors of breast cancer
18. Comparison of uptake of 99m Tc MIBI, 99m Tc tetrofosmin and 99m Tc Q12 into human breast cancer cell line
19. Fractional retention of technetium-99m sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients
20. In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients
21. Bilateral increased uptake of Tc99m sestamibi in scintimammography: Its correlation with the menstrual cycle
22. Technical aspect of prone dependent-breast scintimammography
23. Management of stage three primary breast cancer with primary chemotherapy, surgery and radiation therapy
24. Technetium-99m sestamibi scintimammography: The influence of histopathological characteristics, lesion size, and the presence of carcinoma in situ in the detection of breast carcinoma
25. Imaging of the radiographically dense breast
26. Status of scintimammography and its relationship to other detection methods for breast cancer
27. Prone scintimammography in patients with suspicion of carcinoma of the breast
28. Radionuclide guided stereotactic prebiopsy localization of nonpalpable breast lesions with normal mammogram
29. Diagnostic accuracy of Tc99m sestamibi breast imaging: Multicenter trial results
30. Impact of breast density on the diagnostic accuracy of Tc99m sestamibi breast imaging in the detection of breast cancer
31. Stereotactic techniques for 99m Tc sestamibi guided biopsy of primary breast lesions
32. The positive predictive value of mammography
33. Clinical Validation of the influence of P-glycoprotein on technetium-99m sestamibi uptake in malignant tumors
34. Breast imaging with 99mTc methlene diphosphonate
35. Surface measurement of radioactive phosphorus in breast tumors as possible diagnostic method
36. 99mTc-MIBI mammoscintigraphy of the breast masses: Early and delayed imaging
37. Modulation of the multidrug resistance P-glycoprotein: Detection with technetium-99m-sestamibi in vivo
38. Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using (technetium 99m) sestamibi scintimammography
39. In vitro uptake of Tc99m sestamibi and tizoi
40. Limitations of craniocaudal thallium-201 and Tc99m sestamibi mammoscintigraphy
41. Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein over expression
42. In vitro uptake in bronchial carcinoma
43. Comparison of SPECT and planar Tc99m sestamibi (MIBI) imaging in patients with carcinoma of the breast
44. Negative mammograms in patients with breast cancer
45. Role of thallium 201 chloride and Tc99m methoxy-isobutyl-isonitrile sestamibi in evaluation of breast masses: Correlation with immunohistochemical characteristic parameters Ki-63 PCNA, BCI-2 and angiogenesis in malignant lesions
46. Scintimammography with technetium 99m methoxyisobutylisonitrile comparison with mammography and magnetic resonance imaging
47. Tc99m MIBI scintimammography for suspicious breast lesions
48. The role of Compton background and breast compression on cancer detection in scintimammography. Anticancer Res 17:
49. Multi-PSPMT scintillating camera
50. Detection of MDR with Tc99m sestamibi
51. Functional imaging of multidrug-resistant p-glycoprotein with an organ technetium complex
52. Breast cancer detection with Tc99m tetrofosmin
53. Stereotactic coordinates from ECT sinograms for radionuclide guided biopsy
54. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of breast
55. Tc99m sestamibi: An indicator of breast cancer invasiveness
56. Periodic mammographic follow up of probably benign lesions: Results in 3184 consecutive cases
57. High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer
58. The importance of breast compression during scintimammography (SNM)
59. Correlation of accumulation of Tc 99m methoxy-isobutyl-isonitrile (99mTc sestamibi), antitumorigenic effects of anticarcinogenic agents and expression of P-glycoprotein
60. Positron emission mammography (PEM): A promising technique for detection of breast cancer
61. Feasibility of positron emission mammography
62. Comparison of Tc99m sestamibi scintimammography with contrast enhanced MR imaging for diagnosis of breast lesions
63. Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analog 2-fluorodeoxy-d-glucose
64. Preliminary results for positron emission mammography: Real time functional breast imaging in a conventional mammography gantry
65. High spatial resolution gamma imaging detector based on 5″ diameter R3292 Hamamatsu PSPMT
66. Uptake of Tc99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localization of bone-seeking radiopharmaceutical